Shanghai Fosun Pharmaceutical (Group) Co Ltd
Research Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196.SS) on Bullrun: market cap CNY 61.15B, P/E 17.2, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker600196.SS
- ExchangeSS
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCNY
- Market capCNY 61.15B
- P/E17.2
- Dividend yield1.7%
- Financial periodQ1 2026
- RevenueCNY 10.07B
- Net incomeCNY 870.83M
- Free cash flowCNY 57.23M
- Gross margin49.7%
Valuation Snapshot
latest market cap is CNY 61.15B; P/E is 17.2; dividend yield is 1.7%.
Peer valuation comparison
Latest P/E is 17.22x versus a Healthcare sector median of 21.8x (21.0% below).
Latest dividend yield is 1.7% versus a Healthcare sector median of 2.4% (29.2% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | CNY 61.15B | 17.2 | 1.7% | 0.39 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.39 CNY, yield 1.7%.
About Shanghai Fosun Pharmaceutical (Group) Co Ltd
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others.
ETFs that hold Shanghai Fosun Pharmaceutical (Group) Co Ltd
US-listed ETFs
Shanghai Fosun Pharmaceutical (Group) Co Ltd is held by 34 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares MSCI Emerging Markets ETF (EEM) | <0.01% | 0.72% |
| iShares Core MSCI Emerging Markets ETF (IEMG) | <0.01% | 0.09% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| iShares MSCI ACWI ETF (ACWI) | <0.01% | 0.32% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | <0.01% | 0.04% |
| Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) | 0.12% | 0.65% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shanghai Fosun Pharmaceutical (Group) Co Ltd's market cap?
Shanghai Fosun Pharmaceutical (Group) Co Ltd's market capitalization is CNY 61.15B.
What is Shanghai Fosun Pharmaceutical (Group) Co Ltd's P/E ratio?
Shanghai Fosun Pharmaceutical (Group) Co Ltd's price-to-earnings (P/E) ratio is 17.2.
Does Shanghai Fosun Pharmaceutical (Group) Co Ltd pay a dividend?
Shanghai Fosun Pharmaceutical (Group) Co Ltd has a dividend yield of 1.7%.
What does Shanghai Fosun Pharmaceutical (Group) Co Ltd do?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates.